Zhejiang Xianju Pharmaceutical Co.,Ltd. (SHE:002332)

SHE:002332 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,363	1,382	1,660	1,720	1,267	1,438
Trading Asset Securities	-	-	-	-	500.64	500.44
Cash & Short-Term Investments	1,363	1,382	1,660	1,720	1,768	1,938
Cash Growth	-18.25%	-16.76%	-3.51%	-2.67%	-8.79%	84.59%
Accounts Receivable	925.27	856.66	726.38	706.37	752.24	929.85
Other Receivables	54.54	45.86	15.41	70.84	17.66	18.19
Receivables	979.82	902.52	741.79	777.21	769.9	948.05
Inventory	922.33	930.86	922.88	890.5	910.7	725.66
Other Current Assets	62.47	48.45	75.16	46.11	127.64	137.01
Total Current Assets	3,328	3,264	3,400	3,434	3,576	3,749
Property, Plant & Equipment	2,581	2,549	2,257	2,038	1,997	1,925
Long-Term Investments	297.78	303.56	280.92	278.26	280.21	281.93
Goodwill	602.1	581.21	606.96	573.27	557.57	619.77
Other Intangible Assets	147.77	151.07	166.49	177.18	178.4	184
Long-Term Deferred Tax Assets	34.54	28.76	21.62	28.61	25.39	27.26
Long-Term Deferred Charges	11.87	11.2	10.16	10.19	12.55	15.83
Other Long-Term Assets	126.36	110.78	249.99	197.84	101.12	35.25
Total Assets	7,129	7,000	6,993	6,738	6,728	6,838
Accounts Payable	291.88	309.11	484.51	354.78	385.31	417.72
Accrued Expenses	81.93	99.89	127.86	124.54	175.4	165.61
Short-Term Debt	13.89	8.51	1.03	37.4	65.59	310.77
Current Portion of Long-Term Debt	13.77	19.66	166.36	102.4	346.8	293.07
Current Portion of Leases	-	-	3.47	6.37	6.22	-
Current Income Taxes Payable	53.59	70.85	11	28.43	21.94	42.35
Current Unearned Revenue	22.18	30.62	31.33	46.89	41.9	16.12
Other Current Liabilities	239.65	239.45	221.36	268.26	346.94	373.18
Total Current Liabilities	716.88	778.09	1,047	969.07	1,390	1,619
Long-Term Debt	22.69	20.4	38.74	193.85	313.14	574.45
Long-Term Leases	13.01	10.38	9.75	4.4	7.49	-
Long-Term Unearned Revenue	97.08	97.25	57.86	54.53	59.28	53.84
Long-Term Deferred Tax Liabilities	-	-	-	0.23	-	-
Other Long-Term Liabilities	205.53	205.29	9.53	8.49	8.31	8.75
Total Liabilities	1,055	1,111	1,163	1,231	1,778	2,256
Common Stock	989.2	989.2	989.2	989.2	989.2	989.2
Additional Paid-In Capital	1,841	1,841	1,820	1,803	1,802	1,801
Retained Earnings	3,170	3,027	2,926	2,660	2,059	1,586
Comprehensive Income & Other	32.7	-13.52	50.61	5.74	-15.98	68.46
Total Common Equity	6,034	5,844	5,786	5,457	4,834	4,445
Minority Interest	39.75	44.67	43.92	50.01	115.66	137.42
Shareholders' Equity	6,073	5,888	5,830	5,507	4,950	4,582
Total Liabilities & Equity	7,129	7,000	6,993	6,738	6,728	6,838
Total Debt	63.35	58.95	219.36	344.42	739.25	1,178
Net Cash (Debt)	1,300	1,323	1,441	1,376	1,028	759.77
Net Cash Growth	-11.11%	-8.17%	4.70%	33.81%	35.35%	-
Net Cash Per Share	1.31	1.33	1.46	1.39	1.04	0.83
Filing Date Shares Outstanding	988.9	1,004	989.2	989.2	989.2	989.2
Total Common Shares Outstanding	988.9	1,004	989.2	989.2	989.2	989.2
Working Capital	2,611	2,486	2,353	2,465	2,186	2,130
Book Value Per Share	6.10	5.82	5.85	5.52	4.89	4.49
Tangible Book Value	5,284	5,111	5,013	4,707	4,098	3,641
Tangible Book Value Per Share	5.34	5.09	5.07	4.76	4.14	3.68
Buildings	-	-	1,112	977.17	1,025	1,026
Machinery	-	-	291.83	275.36	1,506	1,443
Construction In Progress	-	-	522.17	374.2	367.9	250.42

Source: S&P Global Market Intelligence. Standard template. Financial Sources.